Table 2. SPARC mRNA expression in tissues from patients with adenocarcinoma and BE.

		SPARC expression
Pathology	n	Median	Range	Interquartile range (25th–75th percentiles)	P-value
EA group	20
Adenocarcinoma		13.79	1.8–105.2	7.79–37.18	<0.001
BE		6.91	0.1–53.62	3.67–13.69
NE		1.79	0.1–16.5	0.59–3.05
BE group	19
BE		2.99	0.09–7.19	0.99–4.97	0.004
NE		1.07	0.29–2.94	0.42–1.52
CG group	10
NE		0.58	0.45–1.17	0.51–0.63

EA=adenocarcinoma group; BE=Barrett's oesophagus group; CG=control group.